Bruce Neal's Publications

About Bruce Neal's Publications

Executive Director, The George Institute for Global Health, Australia

  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:

  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:

  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:

  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:

  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:

  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:

  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:

  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:

  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:

  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:

  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:

  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:

  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:

  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:

  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:

  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published: